Yahoo Canada Web Search

Search results

  1. Beximco Pharmaceuticals Ltd. (Beximco Pharma) is an emerging generic drug player committed to providing access to affordable medicines. Company’s state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of USA, Australia, European Union, Canada, and Brazil, among others, and it currently focuses on building presence in many emerging and developed markets ...

    • About

      It also has the unique distinction as the only Bangladeshi...

    • Products

      Products - Beximco Pharmaceuticals Ltd.

    • Investors

      Investors - Beximco Pharmaceuticals Ltd.

    • Health

      Health - Beximco Pharmaceuticals Ltd.

    • Newsroom

      Beximco Pharmaceuticals Ltd (BPL) is an emerging generic...

    • Contact

      Beximco Pharmaceuticals Ltd (BPL) is an emerging generic...

    • Company Information

      www.beximcopharma.com. Mailing Address. 19 Dhanmondi R/A,...

    • Financial Reports

      Financial Reports - Beximco Pharmaceuticals Ltd.

  2. Beximco Pharma manufacturing facilities are spread across a 20-acre (81,000 m 2) site located in Dhaka, Bangladesh. [13] The facilities consist of a number of purpose-built plants, including a new Oral Solid Dosage (OSD) plant. The site includes manufacturing facilities as well as a research laboratory and a number of warehouses.

  3. en.wikipedia.org › wiki › BEXIMCOBEXIMCO - Wikipedia

    BEXIMCO operates one of the largest integrated textile production businesses in Asia. Its main manufacturing base is the BEXIMCO Industrial Park in Gazipur, Bangladesh. Beximco Pharma, the group's pharmaceutical producer, was the first Bangladeshi company to be listed on the London Stock Exchange.

  4. It also has the unique distinction as the only Bangladeshi Company listed on the AIM of London Stock Exchange. In 2018, Beximco Pharma acquired a majority stake in Nuvista Pharma (formerly Organon Bangladesh), a leading hormone and steroid manufacturer in the country. In 2021, the Company acquired a majority stake (54.6%) in Sanofi Bangladesh ...

  5. Sep 28, 2022 · Beximco’s notable reputation in Bangladesh increased by becoming the exclusive supplier of Serum Institute of India’s COVID-19 vaccine in the country. Between July-December 2021, Beximco distributed eight million doses of this COVID-19 vaccine, facilitated through the Government of Bangladesh. The company also offered full support to ...

  6. www.beximcopharma.com › investors › company-informationBeximco Pharmaceuticals Ltd.

    www.beximcopharma.com. Mailing Address. 19 Dhanmondi R/A, Road No. 7, Dhaka- 1205, Bangladesh. Email. info@bpl.net. Phone. 880-2-58611001-7. Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. BPL is the largest exporter of generic drugs in the ...

  7. People also ask

  8. Mar 25, 2021 · The Bangladeshi company was founded in 1976. Four years later, Beximco Pharmaceuticals started manufacturing products under the licences of Germany-based Bayer and Upjohn of the US, and launched its own formulation brands three years later. In 1985, it was listed on the Dhaka Stock Exchange. Today, Beximco manufactures and markets its own ...

  1. People also search for